This study investigates advanced or refractory solid tumors. It evaluates the effects of a combination of investigational medications on these conditions.
The study focuses on evaluating the safety and effectiveness of the investigational medication combination. It looks at how these medications work together to affect the condition.
- Who can participate: Adults aged 18 and older with advanced or refractory solid tumors can participate. Participants must have measurable disease and have undergone at least one standard treatment for metastatic disease.
- Study details: Participants will take investigational medications by mouth. Some may receive a placebo, an inactive substance that looks like the investigational medicine but does not contain any medicine.
How understandable was the trial content above?
Hard to understand
Easy to understand